Article
Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates.
Cancer research - 15 Jan 2001
Feigelson H S, McKean-Cowdin R, Coetzee G A, Stram D O, Kolonel L N, Henderson B E
Abstract excerpt
We conducted a nested case-control study to evaluate whether polymorphisms in two genes involved in estrogen metabolism, CYP17 and HSD17B1, were useful in developing a breast cancer risk model that could help discriminate women who are at higher risk of breast cancer. If polymorphisms in these ge...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
